Clinical Trial

RESPARK - Brain Q for Chronic Stroke

Recruiting
View on ClinicalTrials.gov →
Summary
This trial tests a promising new intervention to promote post-stroke neural reorganization and functional recovery. The Q Therapeutic (BQ 3.0) is a wearable medical system that produces and delivers non-invasive, extremely-low-intensity and low-frequency, frequency-tuned electromagnetic fields in order to stimulate neuronal networks with the aim of reducing disability and promoting neurorecovery. This trial is a prospective, single-arm, open-label, single center clinical trial designed to evaluate the safety, feasibility, and efficacy of the Q Therapeutic (BQ 3.0) System in the rehabilitation of people with chronic stroke.
Protocol Amendment History 1 change
notable Primary completion pushed: 2026-05 -> 2026-09 2026-07-03
Trial Details
NCT Number NCT07095920
Lead Sponsor University of Florida
Collaborators: BrainQ Technologies Ltd., Brooks Rehabilitation
Conditions Stroke, Chronic Stroke Patients, Cerebrovascular Accident (CVA)
Enrollment 25 participants
Start Date 2025-08-27
Primary Completion 2026-09 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-02